A Phase I Study to Assess the Safety and Immunogenicity of Prime-boost Immunisations With Vaccine Candidates AdCh3NSmut1 and MVA-NSmut in HIV-1 Seropositive HCV-uninfected Adults on Antiretroviral Therapy (ART)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 May 2017
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 02 May 2017 Planned End Date changed from 1 Feb 2017 to 1 Oct 2017.
- 02 May 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Oct 2015 New trial record